|PPTA members produce approximately 80 percent of the plasma protein therapies used in the United States today and more than 60 percent worldwide.|
Zika Virus and Plasma Protein Therapies +
Recent scientific and public press reports have heightened awareness of the Zika virus and its emergence in the Americas (1). The temporal link between the emergence of the virus in Brazil and the birth of babies with microcephaly (2) is most alarming. PPTA is aware that persons who rely on plasma protein therapies are understandably concerned whether these therapies are safe with respect to the Zika virus.
David Bell Elected Chair of PPTA Global Board of Directors +
The Plasma Protein Therapeutics Association (PPTA) Global Board of Directors elected Mr. David Ian Bell as the new Chairman, effective January 2016. Mr. Bell will serve as Chairman for a term of three years.Read More
IQPP Standards Public Comment Period Now Open +
In accordance with the procedures for developing PPTA Voluntary Standards, the following documents are hereby issued for public review, from January 22, 2016 – March 21, 2016.Read More
The Source, the international magazine of the plasma protein therapeutics industry is published quarterly. Read the current issue.